Skip to main content
Equibles
WGS logo

WGS · GeneDx Holdings Corp. · Metrics

Track WGS — free

Use WGS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WGS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$72.18 -0.12 (-0.17%)
Russell 2000 member Rebalance outlook locked
Market Cap
$2.64B
Shares
29.82M
Volume · Sep 30 905.17K Avg daily vol (3M) 724.77K

WGS metrics

73 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$72.30
Market cap
$2.64B

Price action

20 metrics
Price change (1W)
-15.1%
Price change (30D)
-14.8%
Price change (3M)
+0.8%
Price change (6M)
+10.3%
Price change (YTD)
-44.4%
Price change (1Y)
-32.9%
Trailing year
Price change (5Y)
—
52-week high
$167.52
52-week low
$34.51
Change from 52-week high
-56.8%
Change from 52-week low
+109.5%
Annualized volatility
85.0%
Annualized volatility (3M)
68.7%
Beta
1.4
RSI (14D)
35.2
Price vs SMA 50
-10.6%
Price vs SMA 200
-8.7%
Avg volume (3M)
724,770
Relative volume
1.3
Average dollar volume
$55.73M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
29.82M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
5.7×
reciprocal yield 17.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
5.8×
reciprocal yield 17.2%
P / book
10.8
reciprocal yield 9.3%
FCF yield
-2.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.5×
reciprocal yield 22.2%
EV / revenue historical average (5Y)
3.4×
reciprocal yield 29.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
69.4%
Operating margin
-20.3%
Trailing 12 months
Net margin
-23.4%
Gross profit (TTM)
$315.24M
Operating profit (TTM)
−$92.41M
Net income (TTM)
−$106.36M
Trailing 12 months
Diluted EPS (TTM)
$-3.62
FCF margin
-16.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$10.54

Growth

11 metrics
Revenue growth YoY
+11.4%
Year over year
Net income growth YoY
-264.1%
Revenue (TTM)
$454.43M
Trailing 12 months
EPS growth YoY
-266.7%
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+22.1%
Revenue CAGR (5Y)
+19.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-43.5%
Return on assets
-22.1%
Debt / equity
0.4
Current ratio
3.3
EBITDA (TTM)
−$81.51M
Free cash flow (TTM)
−$75.80M
Quick ratio
3.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$35.71M
Latest balance sheet
Cash & equivalents
$60.32M
Total assets
$481.49M
Total debt
$96.84M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$48.71M
Capital expenditures (TTM)
$27.09M
R&D (TTM)
$83.83M
SG&A (TTM)
—
Stock compensation (TTM)
$35.70M
R&D / revenue
18.4%
Stock compensation / revenue
7.9%

Ownership (13F)

3 metrics
13F filers
227
13F filer change QoQ
-19
Institutional ownership
109.7%

Short interest

3 metrics
Short interest
19.7%
Latest settlement · 12.1 days to cover
Days to cover
12.1d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.84M
Insider-sentiment score
25 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1818331 CUSIP 81663L200 13F (30d) 11 filings 7 filers Visit website Investor relations